These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


98 related items for PubMed ID: 7014783

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity.
    Clark A, Potter CW, Jennings R, Nicholl JP, Langrick AF, Schild GC, Wood JM, Tyrrell DA.
    J Hyg (Lond); 1983 Jun; 90(3):361-70. PubMed ID: 6863910
    [Abstract] [Full Text] [Related]

  • 3. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.
    Masurel N, Laufer J.
    J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638
    [Abstract] [Full Text] [Related]

  • 4. Studies with a cold-recombinant A/Victoria/3/75 (H3N2) virus. II. Evaluation in adult volunteers.
    Mortiz AJ, Kunz C, Hofman H, Liehl E, Reeve P, Maassab HF.
    J Infect Dis; 1980 Dec; 142(6):857-60. PubMed ID: 7462697
    [Abstract] [Full Text] [Related]

  • 5. Dose response of cold-adapted, reassortant influenza A/California/10/78 virus (H1N1) in adult volunteers.
    Murphy BR, Clements ML, Madore HP, Steinberg J, O'Donnell S, Betts R, Demico D, Reichman RC, Dolin R, Maassab HF.
    J Infect Dis; 1984 May; 149(5):816. PubMed ID: 6726007
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
    Clark A, Potter CW, Jennings R, Nicholl JP, Langrick AF, Schild GC, Wood JM, Tyrrell DA.
    J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults.
    Keitel WA, Couch RB, Quarles JM, Cate TR, Baxter B, Maassab HF.
    J Infect Dis; 1993 Feb; 167(2):305-11. PubMed ID: 8421165
    [Abstract] [Full Text] [Related]

  • 12. In vitro production of anti-influenza virus antibody after simultaneous administration of H3N2 and H1N1 cold-adapted vaccines in seronegative children.
    Edwards KM, Snyder P, Thompson JM, Johnson PR, Wright PF.
    Vaccine; 1986 Mar; 4(1):50-4. PubMed ID: 3962451
    [Abstract] [Full Text] [Related]

  • 13. Cold-recombinant influenza A/California/10/78 (H1N1) virus vaccine (CR-37) in seronegative children: infectivity and efficacy against investigational challenge.
    Belshe RB, Van Voris LP.
    J Infect Dis; 1984 May; 149(5):735-40. PubMed ID: 6726003
    [Abstract] [Full Text] [Related]

  • 14. Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults.
    Sears SD, Clements ML, Betts RF, Maassab HF, Murphy BR, Snyder MH.
    J Infect Dis; 1988 Dec; 158(6):1209-19. PubMed ID: 3198936
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.